Skip to main content
RBOT logo

RBOT · Vicarious Surgical Inc.

Track RBOT — free
$0.06 +0.00 (+3.45%) At close · Aug 14
Market Cap
$427,453
Shares
7.12M

Vicarious Surgical Inc. Earnings Call Transcripts

Every quarterly earnings call for Vicarious Surgical Inc. (RBOT) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Earnings call
FY25 · Q4
2026-03-09
Vicarious Surgical Inc. Q4 FY2025 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-12
Vicarious Surgical Inc. Q3 FY2025 Earnings Call
Cautious tone Cost Reduction and Cash Burn Outsourcing and Consulting Engagement Clinical Testing and Surgeon Feedback
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-12
Vicarious Surgical Inc. Q2 FY2025 Earnings Call
Balanced tone Leadership Transition System Readiness / Verification Capital Strategy
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-12
Vicarious Surgical Inc. Q1 FY2025 Earnings Call
Positive tone System build-out and preclinical testing Clinical milestones and first patients Financial position and cash runway
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-17
Vicarious Surgical Inc. Q4 FY2024 Earnings Call
Positive tone First Clinical Patients / Regulatory Pathway V1.0 System Integration & Cadaver Lab Hospital System Partnerships
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-12
Vicarious Surgical Inc. Q3 FY2024 Earnings Call
Positive tone Clinical and regulatory pathway Single-port robotic system development Financial discipline and cost management
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-12
Vicarious Surgical Inc. Q2 FY2024 Earnings Call
Positive tone Financial Performance and Cash Runway Regulatory and Clinical Trial Strategy Hospital Partnerships
Diluted EPS
$-2.59
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-04-29
Vicarious Surgical Inc. Q1 FY2024 Earnings Call
Positive tone V1.0 System Development Expense Management / Capital Efficiency Regulatory Pathway (FDA & OUS)
Diluted EPS
$-3.00
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-04
Vicarious Surgical Inc. Q4 FY2023 Earnings Call
Cautious tone V1.0 System Development and Integration Capital Position and Financing Leadership Changes
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-13
Vicarious Surgical Inc. Q3 FY2023 Earnings Call
Diluted EPS
$-3.00
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-07-27
Vicarious Surgical Inc. Q2 FY2023 Earnings Call
Diluted EPS
$-3.62
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-08
Vicarious Surgical Inc. Q1 FY2023 Earnings Call
Diluted EPS
$-6.30
▼ 163.6% YoY
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-13
Vicarious Surgical Inc. Q4 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-07
Vicarious Surgical Inc. Q3 FY2022 Earnings Call
Diluted EPS
$-6.00
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-08
Vicarious Surgical Inc. Q2 FY2022 Earnings Call
Diluted EPS
$-0.30
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-09
Vicarious Surgical Inc. Q1 FY2022 Earnings Call
Diluted EPS
$9.90
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-03
Vicarious Surgical Inc. Q4 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-08
Vicarious Surgical Inc. Q3 FY2021 Earnings Call
Diluted EPS
$-14.70
Audio Transcript Slides 8-K10-Q
Showing 1–18 of 18 earnings calls
Key facts CIK 1812173 CUSIP 92561V208 Visit website